Human Papillomavirus (HPV)
Showing 1 - 25 of >10,000
Women's Values in Managing Human Papillomavirus (HPV)
Not yet recruiting
- Human Papilloma Virus Infection
- No intervention
- (no location specified)
Nov 6, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)
Not yet recruiting
- HPV Associated Cancers
-
New York, New York
- +1 more
Apr 25, 2023
Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Completed
- Human Papillomavirus (HPV)-Related Malignancies
- Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
-
Basking Ridge, New Jersey
- +5 more
Dec 14, 2022
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial
Recruiting
- Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
- +3 more
- Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
-
L'Hospitalet De Llobregat, Catalunya, SpainGynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023
Human Papillomavirus-Related Carcinoma Trial in Seattle (Discussion, Educational Activity, Healthcare Activity)
Recruiting
- Human Papillomavirus-Related Carcinoma
- Discussion
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 26, 2023
Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papillomavirus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023
Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)
Not yet recruiting
- Warts
- Human Papillomavirus 9-valent Vaccine, Recombinant
- Normal Saline
-
Salt Lake City, Utah
- +1 more
Nov 23, 2022
Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papilloma Virus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023
Longitudinal HPV Pap in CIN and VAIN
Recruiting
- Cervical Intraepithelial Neoplasia
- +3 more
- HPV test and Pap Smear
-
Taoyuan City, TaiwanChang Gung Medical Foundation
Jun 27, 2023
Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)(GARDASIL®)
-
Guangzhou, Guangdong, China
- +2 more
Dec 30, 2022
HPV Trial in Hershey (Evalyn Brush)
Terminated
- HPV
- Evalyn Brush
-
Hershey, PennsylvaniaJennifer Moss
Nov 17, 2022
Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant
Active, not recruiting
- Human Papillomavirus Infection
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +5 more
Jan 26, 2023
Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)
Not yet recruiting
- Human Papillomavirus Infection
- Human papillomavirus (HPV) Vaccine
- Placebo
-
Canberra, AustraliaParatus Clinical Research Canberra
Jan 4, 2023
HPV Trial in Hershey (HPV Self-Sampling Kit (Evalyn Brush))
Terminated
- HPV
- HPV Self-Sampling Kit (Evalyn Brush)
-
Hershey, PennsylvaniaPenn State College of Medicine
Nov 17, 2022
High Grade Intraepithelial Trial (HPV detection test)
Not yet recruiting
- High Grade Intraepithelial
- HPV detection test
- (no location specified)
Jul 7, 2022
Verruca Plantaris Trial in Surrey (Sterile water foot bath, Nitric Oxide)
Not yet recruiting
- Verruca Plantaris
- Sterile water foot bath
- Nitric Oxide
-
Surrey, British Columbia, CanadaAchilles Foot Health Centre
May 26, 2023
Modeling From Human Papillomavirus (HPV)
Completed
- GYNAECOLOGICAL INFECTION
-
Paris, FranceHopital La Pitié Salpêtrire
Mar 21, 2022
Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Active, not recruiting
- Human Papillomavirus Infection
- Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
- GARDASIL® 9
-
Kunming, Yunnan, ChinaYunnan Center for Disease Prevention and Control
Dec 23, 2022
Using Human Papillomavirus DNA Testing to Detect HPV-Related
Recruiting
- Oropharyngeal Cancer
- +2 more
- NavDx
-
Basking Ridge, New Jersey
- +6 more
Apr 3, 2023
HPV - Anogenital Human Papilloma Virus Infection, HIV Trial in Brussels (Vaccine)
Active, not recruiting
- HPV - Anogenital Human Papilloma Virus Infection
- HIV Infections
- Vaccine
-
Brussels, BelgiumService de Maladies Infectieuses, CHU Saint-Pierre
Jul 19, 2022
Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human
Active, not recruiting
- Human Papillomavirus Vaccine
- 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
- +2 more
-
Banjul, Outside U.S. And Canada, GambiaEd Clarke
Mar 15, 2022
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
Lichen Planus Trial in Besançon, Paris, Reims (Human biological samples)
Completed
- Lichen Planus
- Human biological samples
-
Besançon, France
- +2 more
Feb 14, 2022
Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 Trial (VTD-101 ointment)
Not yet recruiting
- Vulvar Intraepithelial Neoplasia Grade 2
- Vulvar Intraepithelial Neoplasia Grade 3
- VTD-101 ointment
- (no location specified)
Feb 3, 2023